Xeris Pharmaceuticals (XERS) PT Lowered to $9 at Jefferies
Tweet
Share
E-mailGet Alerts XERS Hot Sheet
Price: $8.43 -0.12%
Rating Summary:
7 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
7 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Jefferies analyst David Steinberg lowered the price target on Xeris Pharmaceuticals (NASDAQ: XERS) to $9.00 (from $11.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- GDS Holdings (GDS) PT Lowered to $51 at Raymond James
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
